Sharp Services

Sharp Services

Pharmaceutical Manufacturing

Allentown, PA 12,406 followers

Packaging | Clinical | Sterile

About us

Sharp is a leader in pharmaceutical packaging, clinical trial supply services & small-scale sterile manufacturing, with a heritage spanning more than 70 years. We partner with pharmaceutical and biotechnology clients, offering solutions and support from phase I trials all the way through to commercial launch and lifecycle management. Together, our 2,200+ strong team leverage the capabilities in state-of-the-art GMP facilities in the US, UK, Belgium, and the Netherlands.

Industry
Pharmaceutical Manufacturing
Company size
1,001-5,000 employees
Headquarters
Allentown, PA
Type
Privately Held
Founded
1993
Specialties
Pharmaceutical Manufacturing Packaging, Labeling, Interactive Response Technologies - IVRS / IWRS, Logistics - Storage, Distribution, Returns, Destruction, QP Services, Analytical & Formulation Development / R&D, Insourcing, and Comparator Sourcing

Locations

Employees at Sharp Services

Updates

  • View organization page for Sharp Services, graphic

    12,406 followers

    New colleagues join the AIR project 🌍 In collaboration with Agilitas Belgium, we welcomed 9 new colleagues to our Hamont facility as part of the international recruiting project (AIR). Over the next six months, these new team members will be working intensively on a dedicated packaging line. Their introduction day began with a warm welcome and introductions, followed by GDP & GMP training and a tour of our facility. We wish our new colleagues the best of luck. Welcome to Sharp! #YourWorkMatters #YourSharpJourneyStartsHere

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +6
  • View organization page for Sharp Services, graphic

    12,406 followers

    View profile for Robert Feltz, graphic

    Director, Analytical and Formulation Services at Sharp Services

    What formulators 𝗻𝗲𝗲𝗱 𝘁𝗼 𝗸𝗻𝗼𝘄 about tablet design? --- Before you start designing your new product, you should know the initial safe starting dose, the maximum tolerated dose, and evaluate how wide the range is between these two values. Now lets design a tablet. If the MTD is relatively high, you should first check your options for size and shape. Large doses = large tablet (usually). Also, issues with patient adherence to a treatment schedule. So, consider this during early product development even when the clinical studies being performed in are well-controlled using healthy volunteers. Also, your marketing group is usually not involved at this stage. Ask any marketer how easy it is to promote a horse pill. Ok, on to some useful info. To establish the tablet weight of a new product, you need to consider some factors and perform some calculations. First, determine the true density of your powder blend, This is a value that represents the density of the solid material without any air spaces. Next, decide on the desired tablet dimensions, including the diameter and thickness. These dimensions will help you calculate the volume of the tablet. Almost there. You can calculate the theoretical weight of a fully dense tablet by multiplying the volume by the true density. However, tablets are not fully dense, so you'll need to account for the solids fraction. The solids fraction refers to the proportion of a mixture's total volume that is occupied by solid particles. It is expressed as a decimal or percentage ranging from 0 to 1 (or 0% to 100%). Now you can calculate the target tablet weight as follows: Target Weight = Solids Fraction (decimal) x Density (weight/volume) x Volume (volume) Keep in mind that this calculated value is theoretical, and you'll need to perform trial compressions to fine-tune the actual tablet weight. Factors such as powder flowability, compressibility, and the specific formulation can affect the final tablet weight. Additionally, you may need to adjust the weight to achieve desired hardness, disintegration time, or dissolution profile. Now, compare the tablet weight at the MTD to the tablet weight at the initial starting dose. Does the formulation scale? Can you maintain proportionality or do you need a dose-similar design, or something else entirely? Last thing: just like different blends will have different true densities, different tablet shapes will have different volumes. Using these variables, you can experiment to see what works best for you. #pharmaceuticals #formulation   --- If you found this interesting or helpful, consider reposting ♻️, follow me, and click the 🔔 so you don't miss future content.

    • No alternative text description for this image
  • View organization page for Sharp Services, graphic

    12,406 followers

    Did you know that Sharp has formulation development, GMP manufacturing and packaging suites, QC release testing and supply chain management solutions all under one roof? Get in touch with Robert Feltz to learn more! #clinicalservices #pharmaceuticals #clinicalresearch #sharpservices

    View profile for Robert Feltz, graphic

    Director, Analytical and Formulation Services at Sharp Services

    3 notes I took from FDA's new Dose Optimization Guidance 📓 --- Instead of simply seeking the maximum tolerated dose, this new guidance recommends optimizing the dosage of human prescription drugs and biological products used to treat oncologic diseases to find a dose that maximizes therapeutic benefits while minimizing toxicity. The guidance encourages sponsors to consider multiple dosages in clinical trials and engage in early discussions with the FDA to ensure that the approved dosage provides the best possible outcomes for patients. The drug formulation section emphasizes: 1. 𝗘𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗗𝗼𝘀𝗮𝗴𝗲𝘀: Planning for various dose strengths allows for a comprehensive evaluation of a drug's efficacy and safety across a range of dosages. This is essential in identifying the optimal dose. No excuses granted for manufacturing difficulty in achieving this. 2. 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝗖𝗼𝗻𝘀𝗶𝗱𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀: For oral formulations, the size and number of tablets or capsules are factors that can influence patient adherence to treatment. If a dose requires an impractically large number of pills or excessively large tablets, patients may struggle to comply with their regimen. Ensuring that the final dosage form is appropriate for the intended patient population enhances the likelihood of adherence and, consequently, the overall effectiveness of the treatment. 3. 𝗦𝗮𝗳𝗲𝘁𝘆 𝗮𝗻𝗱 𝗘𝗳𝗳𝗶𝗰𝗮𝗰𝘆 𝗶𝗻 𝗣𝗮𝗿𝗲𝗻𝘁𝗲𝗿𝗮𝗹 𝗙𝗼𝗿𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: When it comes to parenteral formulations, the final concentration and volume to be administered are vital for ensuring both safety and efficacy. Appropriate concentrations help achieve the desired therapeutic effect without causing toxicity or adverse reactions. Additionally, the volume must be manageable for the patient, as excessively large volumes can lead to discomfort or complications. Link to the guidance is here for your own reading . https://lnkd.in/evwMVRAd And if you're looking for clinical trial supplies for your next study, did you know that Sharp has formulation development, GMP manufacturing and packaging suites, QC release testing, and logistics and supply chain management solutions all under one roof? Send me a message to learn more! #pharmaceuticals #FDA #clinicalresearch  

    Dose Optimization in Oncology

    Dose Optimization in Oncology

    fda.gov

  • View organization page for Sharp Services, graphic

    12,406 followers

    We successfully installed our new chillers at our Sharp facility in Hamont, Belgium. Each chiller has a capacity of 326 kW and is equipped with the latest energy-saving features. This upgrade marks a step in enhancing our operational efficiency and cooling capabilities. Thank you to our suppliers Technigroup and everyone involved in making this project a success!   #FacilityUpgrade #PharmaPackaging #OperationalEfficiency #TeamSharp

  • Sharp Services reposted this

    Join us in São Paulo on August 21 and 22 for the session "Case Study on Automated Kit-packing of Hypodermic Needles with Injectable Drugs." Philippe Lauwers and Alexander Schäfer will discuss the design specifics of automated packing, the engineering complexities of needle development, and the importance of alignment among pharmaceutical companies, needle suppliers, and contract packers. Terumo Pharmaceutical Solutions Division, part of Terumo Medical Corporation, is globally trusted for its quality and precision in developing #HealthcareInnovation and #PharmaceuticalSolutions. 📅 Save the date: August 21-22, 2024 📌 Register now: https://lnkd.in/d5RTHdk2 #BiosimilarsLatAm #parenteraldrugdelivery #biotech #HealthcareInnovation

    • No alternative text description for this image
  • Sharp Services reposted this

    View profile for Tracey Safran, graphic

    Director | Business Development | CDMO

    I’ll be attending ChemOutsourcing Week in Parsippany, NJ from September 3rd to 6th! If you’re also going, let’s connect and discuss your analytical testing needs for small molecules. Looking forward to meeting you there! 🔬🔍 #ChemOutsourcing2024 #smallmolecules #analyticaltesting #sharpservices https://lnkd.in/extcr8Gq

    2024 Chem Outsourcing Conference For Pharmaceutical Professionals

    2024 Chem Outsourcing Conference For Pharmaceutical Professionals

    chemoutsourcing.com

Affiliated pages

Similar pages

Browse jobs

Funding

Sharp Services 1 total round

Last Round

Debt financing

US$ 712.5M

See more info on crunchbase